4th Quarter - Report

ACG ADVOCACY for GENENTECH INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Pandemic Preparedness Tamiflu Avastin - Use in breast cancer treatment

LobbyistCovered position, as disclosed
IAN P MUSSELMAN —
DAVID J URBAN Chief of Staff, Senator Arlen Specter

Contacted: SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.